Related references
Note: Only part of the references are listed.Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension
Joanna Saleby et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2017)
An Update on the Management of Chronic Thromboembolic Pulmonary Hypertension
Justin A. Edward et al.
CURRENT PROBLEMS IN CARDIOLOGY (2017)
Beyond a single pathway: combination therapy in pulmonary arterial hypertension
Olivier Sitbon et al.
EUROPEAN RESPIRATORY REVIEW (2016)
Chronic thromboembolic pulmonary hypertension is not associated with iron overload
Qunying Xi et al.
CARDIOVASCULAR PATHOLOGY (2015)
Pulmonary microvascular lesions regress in reperfused chronic thromboembolic pulmonary hypertension
David Boulate et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
Oxidative stress and nitric oxide signaling related biomarkers in patients with pulmonary hypertension: a case control study
Shuai Zhang et al.
BMC PULMONARY MEDICINE (2015)
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Comprehensive analysis of inflammatory markers in chronic thrornboembolic pulmonary hypertension patients
Diana Zabini et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Long-term advanced therapy with bosentan improves symptoms and prevents deterioration of inoperable chronic thromboembolic pulmonary hypertension
M. Nishikawa-Takahashi et al.
LIFE SCIENCES (2014)
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension
Marion Delcroix et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Piglet model of chronic pulmonary hypertension
Olaf Mercier et al.
PULMONARY CIRCULATION (2013)
Evidence for Rho-Kinase Activation in Patients With Pulmonary Arterial Hypertension
Zhulanqiqige Do E et al.
CIRCULATION JOURNAL (2009)
Control of pulmonary vascular tone during exercise in health and pulmonary hypertension
Daphne Merkus et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Share Paper
